It is unclear why RAD21 binding is enriched in MCF7 but not the other breast cancer cells, but it is possible that interaction between the C SNP enhancer and the MYC promoter contributes to regulation of MYC in MCF7 cells. Here, RAD21 is linked to breast carcinoma.